Explanation and interpretation of blood transfusion provisions for children with hematological diseases in the national health standard "Guideline for pediatric transfusion".
- Author:
Ming-Yi ZHAO
1
;
Rong HUANG
;
Rong GUI
;
Qing-Nan HE
1
;
Ming-Yan HEI
;
Xiao-Fan ZHU
;
Jun LU
;
Xiao-Jun XU
;
Tian-Ming YUAN
;
Rong ZHANG
;
Xu WANG
;
Jin-Ping LIU
;
Jing WANG
;
Zhi-Li SHAO
;
Yong-Jian GUO
;
Xin-Yin WU
;
Jia-Rui CHEN
;
Qi-Rong CHEN
;
Jia GUO
;
Ming-Hua YANG
1
Author Information
- Publication Type:Journal Article
- Keywords: Acute leukemia; Aplastic anemia; Autoimmune hemolytic anemia; Child; Thalassemia; Thrombocytopenia
- MeSH: Humans; Child; Hematologic Diseases/therapy*; Blood Transfusion/standards*; Practice Guidelines as Topic
- From: Chinese Journal of Contemporary Pediatrics 2025;27(1):18-25
- CountryChina
- Language:Chinese
- Abstract: To guide clinical blood transfusion practices for pediatric patients, the National Health Commission has issued the health standard "Guideline for pediatric transfusion" (WS/T 795-2022). Blood transfusion is one of the most commonly used supportive treatments for children with hematological diseases. This guideline provides guidance and recommendations for blood transfusions in children with aplastic anemia, thalassemia, autoimmune hemolytic anemia, glucose-6-phosphate dehydrogenase deficiency, acute leukemia, myelodysplastic syndromes, immune thrombocytopenic purpura, and thrombotic thrombocytopenic purpura. This article presents the evidence and interpretation of the blood transfusion provisions for children with hematological diseases in the "Guideline for pediatric transfusion", aiming to assist in the understanding and implementing the blood transfusion section of this guideline.
